Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury

NCT00148239 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2015-12-02

No results posted yet for this study

Summary

The overall objective of this project is to test the efficacy of an innovative multi-component intervention aimed at reducing the risk for adverse health outcomes among caregivers of older survivors with spinal cord injury or disability, and to improve the well being of the spinal cord-injured survivor. In a three-group, randomized, controlled design providing access to information, resources, and support, we predict that the dual target approach will have a greater positive impact on both the caregiver and survivor than the caregiver-only approach, and that both active treatments will be superior with respect to caregiver outcomes than an information-only control condition.

Conditions

  • Spinal Cord Injuries

Interventions

BEHAVIORAL

Caregiver Only Intervention

A multi-component psycho-educational intervention designed to reduce the negative emotional and behavioral responses of the caregiver and reduce the risk of mental and physical health problems.

BEHAVIORAL

Dual Treatment

Complements the caregiver only intervention by targetting both caregiver and SCI person with multi-component psycho-educational intervention

BEHAVIORAL

Control

Participants given written educational materials at beginning of study; no treatment beyond this

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER
  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Richard Schulz, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2007-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00148239 on ClinicalTrials.gov